Clinical Trial Update: Paclitaxel With or Without Trastuzumab Following Peripheral Stem Cell Transplantation in Treating Patients With Refractory Stage IV Breast Cancer [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating paclitaxel with or without trastuzumab after peripheral stem cell transplantation in patients with metastatic breast cancer ha…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• PACLITAXEL (PACLITAXEL)
• Trastuzumab (trastuzumab)

Snippet

Sponsor: Fred Hutchinson Cancer Center | Conditions: Breast Cancer | Phase 2 | Status: COMPLETED